1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARBUTUS BIOPHARMA CORP
Arbutus Biopharma Corp
XNAS: ABUS
5.01 -0.06 (-1.18%)
6.5M
XNAS Volume

XNAS 18 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Arbutus Biopharma Corp - ABUS - stock price prediction, stock price target, analyst ratings from 1 analyst

Arbutus Biopharma Corp has a share price target of US$ 5, revenue growth forecast of 1181.0%, and profit growth estimate of 561.6% for FY26, based on top 1 analyst call.